US FDA approves Tecentriq with chemotherapy for stage III dMMR colon cancer
The US FDA approved Tecentriq with chemotherapy for stage III dMMR colon cancer.
1. FDA approval
The FDA also approved atezolizumab and hyaluronidase-tqjs in combination with fluoropyrimidine and oxaliplatin for stage III dMMR colon cancer.
